High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells

被引:87
作者
Miura, S [1 ]
Fujino, M [1 ]
Matsuo, Y [1 ]
Kawamura, A [1 ]
Tanigawa, H [1 ]
Nishikawa, H [1 ]
Saku, K [1 ]
机构
[1] Fukuoka Univ, Sch Med, Dept Cardiol, Jonan Ku, Fukuoka 8140180, Japan
关键词
high density lipoprotein; Ras; mitogen-activated protein kinase; human coronary artery endothelial cells;
D O I
10.1161/01.ATV.0000066134.79956.58
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Plasma high density lipoprotein (HDL) levels have been shown to be inversely correlated with coronary artery disease, but the mechanisms of the direct protective effect of HDL on endothelial cells (ECs) are not fully understood. In this study, we investigated the role of the HDL-mediated promotion of angiogenesis in human coronary artery ECs (HCECs). Methods and Results - We developed an in vitro model of HCEC tube formation on a matrix gel. We optimized the maximum dose of HDL required to induce tube formation in initial experiments, in which the dose response showed that the maximum effective dose of HDL was 100 mug/mL. PD98059, an inhibitor of p42/44 mitogen-activated protein kinase ( MAPK) activity, but not SB203580, an inhibitor of p38 MAPK activity, suppressed HDL-induced tube formation. Dominant-negative Ras N17 inhibited HDL-induced tube formation. HDL activated Ras according to a ras pull-down assay, and this effect was inhibited by pertussis toxin. Moreover, HDL activated phospho( p)- p42/44 MAPK, whereas Ras N17 blocked HDL-induced pp42/44 MAPK. Conclusions - These results indicate that HDL induced a potent signal through a Ras/MAPK pathway mediated by a pertussis toxin - sensitive G-protein coupled receptor to the angiogenic phenotype in HCECs.
引用
收藏
页码:802 / 808
页数:7
相关论文
共 26 条
[1]   Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells [J].
Ashby, DT ;
Rye, KA ;
Clay, MA ;
Vadas, MA ;
Gamble, JR ;
Barter, PJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (09) :1450-1455
[2]  
DARBON JM, 1986, J BIOL CHEM, V261, P8002
[3]  
Dimmeler S, 2000, CIRC RES, V87, P434
[4]   Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability [J].
Eliceiri, BP ;
Paul, R ;
Schwartzberg, PL ;
Hood, JD ;
Leng, J ;
Cheresh, DA .
MOLECULAR CELL, 1999, 4 (06) :915-924
[5]  
GORDON DJ, 1989, NEW ENGL J MED, V321, P1311
[6]   Therapeutic angiogenesis for heart failure [J].
Isner, JM ;
Losordo, DW .
NATURE MEDICINE, 1999, 5 (05) :491-492
[7]   Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization [J].
Isner, JM ;
Asahara, T .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1231-1236
[8]  
KAHLON R, 1992, CAN J CARDIOL, V8, P60
[9]   'Accidental' anti-angiogenic drugs: anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples [J].
Kerbel, RS ;
Viloria-Petit, A ;
Klement, G ;
Rak, J .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (10) :1248-1257
[10]   Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells [J].
Kimura, T ;
Sato, K ;
Kuwabara, A ;
Tomura, H ;
Ishiwara, M ;
Kobayashi, I ;
Ui, M ;
Okajima, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :31780-31785